Global Prefilled Syringes Market Segmentation, By Product Type (Conventional Prefilled Syringes, Safety Prefilled Syringes), Material Type (Glass Prefilled Syringes, Plastic Prefilled Syringes), Closing System (Staked Needle System, Luer Cone System, Luer Lock System), Design (Single-Chamber Prefilled Syringes, Dual- Chamber Prefilled Syringes, Customized Prefilled Syringes), Application (Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer, Thrombosis, Ophthalmology, Others), End User (Hospitals, Mail Order Pharmacies, Ambulatory Surgery Centers, Others) – Industry Trends and Forecast to 2031.
Prefilled Syringes Market Analysis
Over the recent years, there is growing trend toward plastic and disposable syringes, which protect the needle and prevent it from being reused (prefilled disposable systems). This has boosted demand for prefilled syringes in the medical industry, which are more convenient and safe than traditional glass vials for carrying parental medications.
Prefilled Syringes Market Size
Global prefilled syringes market size was valued at USD 7.35 billion in 2023 and is projected to reach USD 15.19 billion by 2031, with a CAGR of 9.50% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Prefilled Syringes Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
|
|
Key Market Players
|
BD (U.S), Gerresheimer AG (Germany), SCHOTT (Germany), West Pharmaceutical Services, Inc. (U.S), Baxter (U.S), Catalent, Inc. (US), Weigao Group (China), Vetter Pharma (Germany), Nipro (Japan), Elcam Medical (Israel), YPSOMED AG (Switzerland), ), F. Hoffmann-La Roche Ltd., (Switzerland), Thermo Fisher Scientific Inc., (US), Bruker (U.S), Abbott (U.S), Immunexpress Inc. (U.S), Oval Medical Technologies Ltd., (UK), Boditech Med Inc., (South Korea), SHL Medical AG (Switzerland) and Terumo Corporation (Japan)
|
Prefilled Syringes Market Definition
Prefilled syringes are basically single-dose containers of parenteral medication fitted with a needle by the manufacturer. By lowering the risk of unintended needle sticking and harmful product exposure that can occur while drawing medication from vials, prefilled syringes improve patient safety.
Prefilled Syringes Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
- Increased Usage For Health Conditions
The various issues such as the chronic conditions that basically involve heart diseases, diabetes, autoimmune diseases and others generally require patients to opt for self-administer medications, which increases the adoption of prefilled syringes, This is considered to be one of the most significant factor driving the growth for this market. Additionally, the prevalence of various kinds of chronic and lifestyle diseases is also expected to accelerate the market's overall growth.
- Ease In Usage Will Boost The Growth
They are easy to use due to the convenience and safety associated with their market use. Consequently, there has been a growth in the demand for self-injection and related devices, and their easy usage is also expected to fuel market growth.
- Safety Features to Cushion The Market Growth
Moreover, the prefilled syringes improve patient safety by lowering the risk of unintended needle sticking and harmful product exposure that can occur while drawing medication from vials which also cushions the market's growth within the forecasted period.
In addition to this, the surging number of biologics and biosimilars in the pharmaceuticals market, high demand for advanced drug delivery devices for accurate dosing, and the rising adoption of self-injecting parenteral devices are also projected to bolster the growth of the market.
Opportunities
- Growing Awareness and Supportive Regulations To Offer Growth Opportunities
Moreover, supportive government regulations (especially needle stick legislations) are estimated to generate lucrative opportunities for the market. The growing awareness on the benefits of prefilled syringes among patients and healthcare professionals will further offer numerous growth opportunities for the market.
Restraints/Challenges
- Risk of Injuries
According to the available data, a large proportion of needle stick injuries are linked to the increased usage of bare prefilled syringes compared to those with integrated safety devices. This factor is expected to obstruct market growth.
- Availability of Cheaper Alternatives
Also, the prefilled syringes are much expensive as compared to the disposable syringes because of the high costs associated with their production. The availability of its alternative that is disposable syringes at a lower cost is projected to pose as a major challenge for the prefilled syringes market in the forecast period of 2024-2031.
This prefilled syringes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the prefilled syringes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Post Covid-19 Impact on Prefilled Syringes Market
The global prefilled syringes market was immensely effected by the outbreak of COVID-19. The market had to undergo various challenges due to the pandemic. The imposition of the lockdown and social distancing regulations by the government to basically curb the COVID-19 pandemic outbreak, led to halt of various operations, supply chain disruptions, stifling business growth, technology event cancellations, suspensions of new developments and has affected the overall production and sales, which limited the industry's expansion for short-term.
Furthermore, new ways of delivering care by healthcare professionals such as telemedicine, to lessen face-to-face interaction and also the adoption of the new virtual and digital healthcare technologies is critical to keep their regular visits. Moreover, the utilization of apps can aid in the self-management of chronic illnesses such as diabetes, when continuous glucose monitoring is possible. Similarly, community pharmacists' contributions to managing chronic diseases and promoting drug adherence will be critical in lessening the burden on already overburdened health services during the COVID-19 epidemic.
Prefilled Syringes Market Scope
The prefilled syringes market is segmented on the basis of product type, material type, closing system, design, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Conventional Prefilled Syringes
- Safety Prefilled Syringes
Material Type
- Glass Prefilled Syringes
- Plastic Prefilled Syringes
Closing System
- Staked Needle System
- Luer Cone System
- Luer Lock System
Design
- Single-Chamber Prefilled Syringes
- Dual- Chamber Prefilled Syringes
- Customized Prefilled Syringes
Application
- Diabetes
- Rheumatoid Arthritis
- Anaphylaxis
- Cancer
- Thrombosis
- Ophthalmology
- Others
End User
- Hospitals
- Mail Order Pharmacies
- Ambulatory Surgery Centers
- Others
Prefilled Syringes Market Regional Analysis
The prefilled syringes market is analyzed and market size insights and trends are provided by country, product type, material type, closing system, design, application and end user as referenced above.
The countries covered in the prefilled syringes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Europe dominates the prefilled syringes market because of the high adoption of patient safety measures, key manufacturers' geographical expansion, and the high adoption of self-injection devices within the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rapid technological advancements and growing demand for injectable drugs for the treatment of chronic and lifestyle related diseases in countries such as India and China within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Prefilled Syringes Market Share
The prefilled syringes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to prefilled syringes market.
Prefilled Syringes Market Leaders Operating in the Market Are:
- BD (U.S)
- Gerresheimer AG (Germany)
- SCHOTT (Germany)
- West Pharmaceutical Services, Inc. (U.S)
- Baxter (U.S)
- Catalent, Inc. (US)
- Weigao Group (China)
- Vetter Pharma (Germany)
- Nipro (Japan)
- Elcam Medical (Israel)
- YPSOMED AG (Switzerland)
- F. Hoffmann-La Roche Ltd., (Switzerland)
- Thermo Fisher Scientific Inc., (US)
- Bruker (U.S)
- Abbott (U.S)
- Immunexpress Inc. (U.S)
- Oval Medical Technologies Ltd., (UK)
- Boditech Med Inc., (South Korea)
- SHL Medical AG (Switzerland)
- Terumo Corporation (Japan)
Latest Developments in Prefilled Syringes Market
- In December 2020, BD (Becton, Dickinson and Company), a leading global medical technology company, announced plans to invest $1.2 billion over four years. This investment is made to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) and advanced drug delivery systems (ADDS) at its six global manufacturing locations and open a new manufacturing facility in Europe. By the end of 2023, the new manufacturing site in Europe should be operating.
SKU-